Status:
UNKNOWN
Study on Exosome Changes in Patients With Proliferative Diabetic Retinopathy
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Brief Summary
Diabetic retinopathy is a common complication of diabetes and one of the leading causes of low vision and blindness in adults. In recent years, the prevalence of diabetes and the incidence of diabetic...
Detailed Description
一、Research Purpose 1. compared the changes of exosomes in intraocular fluid and blood of patients with proliferative diabetic retinopathy and non-diabetic patients. 2. analysed differentially express...
Eligibility Criteria
Inclusion
- Age ≥18 years old;
- Patients diagnosed with PDR by FFA and requiring vitrectomy for treatment;
- Patients with no history of diabetes and diagnosed with macular anterior membrane or macular hiatus by color fundus photography and OCT;
- Sign the informed consent form.
Exclusion
- Suffering from cancer, immune diseases, infectious diseases and other systemic diseases;
- Patients with retinal arteriovenous obstruction;
- Intraocular infection;
- Patients with uveitis;
- In patients with high myopia, the equivalent spherical lens was \> -9.0D;
- Recent history of cerebral infarction, myocardial infarction and other thrombus;
- Patients with contraindications to surgery.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06198543
Start Date
January 1 2024
End Date
April 1 2025
Last Update
January 10 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.